Loading organizations...
Loading organizations...
Pharmaceuticals specializing in Alzheimer's and brain disease solutions.
Amylyx Pharmaceuticals has raised $171.9M across 4 funding rounds.
Amylyx Pharmaceuticals has raised $171.9M in total across 4 funding rounds.
Amylyx Pharmaceuticals has raised $171.9M in total across 4 funding rounds.
Amylyx Pharmaceuticals's investors include Viking Global Investors, Belinda Termeer, 683 Capital Management, Bain Capital Life Sciences, Falcon Edge Capital, Marshall Wace, Morningside Ventures, Perceptive Advisors, Polaris Founders Capital, Rock Springs Capital, Tybourne Capital Management, Verition Fund Management.
Amylyx Pharmaceuticals has raised $171.9M across 4 funding rounds. Most recently, it raised $135.0M Series C in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 20, 2021 | $135.0M Series C | Viking Global Investors | Belinda Termeer, 683 Capital Management, Bain Capital Life Sciences, Falcon Edge Capital, Marshall Wace, Morningside Ventures, Perceptive Advisors, Polaris Founders Capital, Rock Springs Capital, Tybourne Capital Management, Verition Fund Management, Woodline Partners |
| Jul 1, 2020 | $30.0M Series B | Isaac Cheng | |
| Aug 22, 2016 | $5.0M Series A | Isaac Cheng | Henri Termeer, Felix Coerper |
| Nov 17, 2015 | $1.9M Other Equity | Merit Cudkowicz, Cure Alzheimer |